MFN Partners, LP 13D and 13G filings for Aclaris Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-07-22 3:04 pm Sale |
2020-07-20 | 13G | Aclaris Therapeutics, Inc. ACRS |
MFN Partners, LP | 1,895,677 4.530% |
-2,104,323 (-52.61%) |
Filing |